MPD: All measures mapped to paradigm code 'timecourse'

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Attie2:15	Attie2	body weight	high-fat high-sucrose diet	body weight after diet [g] bw 110632 wk: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (5 more)...	DO population		both	5-26wks	N=250	2018

Attie2:37	Attie2	body weight	high-fat high-sucrose diet	change in body weight after diet (compared to wk 1) [g] bw_chg 110654 wk: 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17	DO population		both	6-21wks	N=250	2018

Attie2:54	Attie2	intake monitoring	high-fat high-sucrose diet	food consumption after diet [g] food 110671 wk: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (4 more)...	DO population		both	5-25wks	N=250	2018

Attie2:76	Attie2	metabolic panel	high-fat high-sucrose diet	plasma glucose after diet (4h fast) [mg/dL] GLU 110693 wk: 6 10 14 22	DO population		both	10-26wks	N=250	2018

Attie2:80	Attie2	hormone quantification	high-fat high-sucrose diet	plasma insulin after diet (4h fast) [ng/mL] INS 110697 wk: 6 10 14 22	DO population		both	10-26wks	N=250	2018

Attie2:84	Attie2	lipid profile	high-fat high-sucrose diet	plasma triglyceride after diet (4h fast) [mg/dL] TG 110701 wk: 6 10 14 22	DO population		both	10-26wks	N=250	2018

Bennett1:1	Bennett1	body weight	(none)	body weight [g] bw 36701 age (days): 30 60 90 120 150 180	ILSXISS	97	f	4wks	N=5	2005

Bennett3:1	Bennett3	alcohol quantification	ethanol	blood ethanol concentration (BEC) [mg/mL] BEC 37501 first loss of balance (ataxia) first regain of balance second regain of balance	ILSXISS w/par	74	both	8-14wks	N=5	2007

Bolivar1:1	Bolivar1	open field test	(none)	horizontal activity (beam breaks), 5 min test in dark [n] horiz_act 63401 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:4	Bolivar1	open field test	(none)	number of horizontal movement episodes, 5 min test in dark [n] horiz_bouts 63404 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:7	Bolivar1	open field test	(none)	percentage of time spent moving, 5 min test in dark [%] move_time_pct 63407 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:10	Bolivar1	open field test	(none)	percentage of time spent resting, 5 min test in dark [%] rest_time_pct 63410 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:13	Bolivar1	open field test	(none)	vertical activity (beam breaks), 5 min test in dark [n] vert_act 63413 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:16	Bolivar1	open field test	(none)	number of vertical movement episodes, 5 min test in dark [n] vert_bouts 63416 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:19	Bolivar1	open field test	(none)	percentage of time spent vertical, 5 min test in dark [%] vert_time_pct 63419 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:22	Bolivar1	open field test	(none)	stereotypic activity (beam breaks), 5 min test in dark [n] stereo_act 63422 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:25	Bolivar1	open field test	(none)	number of stereotypic movement episodes, 5 min test in dark [n] stereo_bouts 63425 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:28	Bolivar1	open field test	(none)	percentage of time spent moving stereotypically, 5 min test in dark [%] stereo_time_pct 63428 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:31	Bolivar1	open field test	(none)	number of clockwise revolution episodes, 5 min test in dark [n] c_revs 63431 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:34	Bolivar1	open field test	(none)	number of counter-clockwise revolution episodes, 5 min test in dark [n] cc_revs 63434 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:37	Bolivar1	open field test	(none)	distance traveled, 5 min test in dark [cm] tot_dist 63437 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:40	Bolivar1	open field test	(none)	distance traveled in periphery, 5 min test in dark [cm] margin_dist 63440 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:43	Bolivar1	open field test	(none)	percentage of time spent in periphery, 5 min test in dark [%] margin_time_pct 63443 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:46	Bolivar1	open field test	(none)	distance traveled in center, 5 min test in dark [cm] center_dist 63446 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:49	Bolivar1	open field test	(none)	percentage of time spent in center, 5 min test in dark [%] center_time_pct 63449 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:52	Bolivar1	open field test	(none)	percentage of time spent in left-front of arena, 5 min test in dark [%] LF_time_pct 63452 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:55	Bolivar1	open field test	(none)	percentage of time spent in right-front of arena, 5 min test in dark [%] RF_time_pct 63455 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:58	Bolivar1	open field test	(none)	percentage of time spent in left-rear of arena, 5 min test in dark [%] LR_time_pct 63458 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:61	Bolivar1	open field test	(none)	percentage of time spent in right-rear of arena, 5 min test in dark [%] RR_time_pct 63461 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar2:1	Bolivar2	fear conditioning test	(none)	activity (beam breaks) during 2.5 min period of training on day 1 [n] act_shock 63901 before shock after 1st shock after 2nd shock after 3rd shock	inbred	8	both	9-20wks	N=18	2001

Bolivar2:6	Bolivar2	fear conditioning test	(none)	activity (beam breaks) during 1 min period of contextual conditioning on day 2 [n] act_context 63906 1st min 2nd min 3rd min 4th min 5th min mean	inbred	8	both	9-20wks	N=18	2001

Bolivar2:13	Bolivar2	fear conditioning test	(none)	activity (beam breaks) during 1 min period of altered context on day 2 [n] act_altered 63913 1st min 2nd min 3rd min mean	inbred	8	both	9-20wks	N=18	2001

Bolivar2:17	Bolivar2	fear conditioning test	(none)	activity (beam breaks) during 1 min period of cued conditioning on day 2 [n] act_cued 63917 1st min 2nd min 3rd min mean	inbred	8	both	9-20wks	N=18	2001

Bolivar4:1	Bolivar4	open field test	(none)	distance traveled on day 1, 15 min test [cm] dist_5min_d1 64701 first 5 min second 5 min third 5 min	inbred	14	m	8-12wks	N=18	2009

Bolivar4:5	Bolivar4	open field test	(none)	distance traveled, 15 min test [cm] dist_15min 64705 day 1 day 2 day 3	inbred	14	m	8-12wks	N=18	2009

Brinkmeyer1:1	Brinkmeyer1	body weight	Theiler's murine encephalomyelitis virus	body weight, post infection [g] bw 64401 day 0 day 2 day 4 day 6 day 8 day 10 day 14 day 17 day 22 day 27 (6 more)...	CC	5	both	4wks	N=5	2017

Brinkmeyer1:17	Brinkmeyer1	health assessment	Theiler's murine encephalomyelitis virus	clinical score (0=normal, 6=moribund), post infection [score] clin_score 64417 day 0 day 2 day 4 day 6 day 8 day 12 day 18 day 24 day 29 day 34 (6 more)...	CC	5	both	4wks	N=5	2017

Brinkmeyer1:187	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	length of forelimb steps as measured by foot print analysis, post infection [cm] length_fore 64587 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:194	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	width of forelimb steps as measured by foot print analysis, post infection [cm] width_fore 64594 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:201	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	length of hindlimb steps as measured by foot print analysis, post infection [cm] length_hind 64601 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:208	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	width of hindlimb steps as measured by foot print analysis, post infection [cm] width_hind 64608 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Cheverud1:1	Cheverud1	body weight	(none)	body weight on control diet [g] bw_ctrl 17801 age (wks): 4 5 6 7 9 11 15 19 23	LGXSM w/par	17	both	12-16wks	N=8	2004

Cheverud1:59	Cheverud1	body weight	high-fat diet	body weight on high-fat diet [g] bw_hifat 17851 age (wks): 4 5 6 7 9 11 15 19 23	LGXSM w/par	18	both	12-16wks	N=8	2004

Crabbe4:12	Crabbe4	alcohol quantification	ethanol	blood ethanol concentration [mg/mL] BEC 19112 time after ethanol: 30min 60min 105min 150min	inbred	21	both	7-12wks	N=6	2003

Crowley1:1	Crowley1	body weight	haloperidol	body weight [g] bw 39401 starting ending	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:3	Crowley1	drug and metabolite quantification	haloperidol	plasma haloperidol concentration [nM] haloperidol 39403 day: 30 60 90 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:7	Crowley1	inclined screen test	haloperidol	latency to move four paws, extrapyramidal side effects [s] latency 39407 day: 0 3 7 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:12	Crowley1	open field test	haloperidol	distance traveled, 60 min test [cm] horizontal_act 39412 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:17	Crowley1	open field test	haloperidol	vertical activity, beam breaks, 60 min test [n] vertical_act 39417 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:21	Crowley1	open field test	haloperidol	repetitive behavior, breaking of same beam, 60 min test [n] stereotypy 39421 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:25	Crowley1	open field test	haloperidol	center occupancy, percentage of total time [%] pct_center 39425 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:29	Crowley1	behavior observation	haloperidol	tongue protrusions, 15 min test [n] tongue 39429 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:33	Crowley1	behavior observation	haloperidol	overt chewing movements, 15 min test [n] overtchew 39433 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:37	Crowley1	behavior observation	haloperidol	subtle chewing movements, 15 min test [n] subtlechew 39437 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:41	Crowley1	behavior observation	haloperidol	jaw tremor duration, 15 min test [s] jawtremor 39441 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crusio1:16	Crusio1	radial maze	(none)	time to complete task [s] task_time 62016 day 1 day 2 day 3 day 4 day 5	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:21	Crusio1	radial maze	(none)	number of different arms visited during first 8 arm choices of a trial [n] num_arms 62021 day 1 day 2 day 3 day 4 day 5	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:26	Crusio1	radial maze	(none)	number of different arms visited during first 8 arm choices of a trial minus 5.3 (number expected by chance) [n] num_arms_adj 62026 day 3 day 4 day 5 mean	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:30	Crusio1	radial maze	(none)	number of errors made before all 8 rewards collected [n] errors 62030 day 1 day 2 day 3 day 4 day 5 sum of days 3 4 5	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:36	Crusio1	radial maze	(none)	mean duration per arm visit (including errors) [s] visit_time 62036 day 3 day 4 day 5 mean	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:40	Crusio1	behavior observation	(none)	attack latency [s] latency 62040 day 1 day 2	BXD w/par	55	m	12-16wks	N=8	2018

Crusio1:42	Crusio1	behavior observation	(none)	whether an animal attacks (0=no, 1=yes) [score] attack 62042 day 1 day 2	BXD w/par	55	m	12-16wks	N=8	2018

CSNA02:1	CSNA02	open field test	(none)	distance traveled, 40 min test [cm] locomotor 62201 day 1 day 2 day 2 minus day 1	inbred	10	both	10wks	N=8	2018

CSNA02:20	CSNA02	body weight	(none)	body weight for ethanol study [g] bw 62220 day 1 day 2 day 3	inbred	18	both	16-39wks	N=6	2018

CSNA02:23	CSNA02	bottle choice test	ethanol	ethanol consumption adjusted per kg body weight 'drinking in the dark' [g/kg] EtOH_adj 62223 day 1 day 2 day 3	inbred	18	both	16-39wks	N=6	2018

CSNA02:26	CSNA02	bottle choice test	ethanol	licks on ethanol bottle as a percentage of total licks 'drinking in the dark' [%] EtOH_licks 62226 day 1 day 2 day 3	inbred	18	both	16-39wks	N=5	2018

CSNA03:19	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), founders [cm] amb_dist_OFT_in 90019 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:31	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:43	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), DO [cm] amb_dist_OFT_do 90021 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:334	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, founders [cm] dist_f30_cont_in 90328 day: 1 2 3 5 7 9 11 12 19	inbred w/CC8	9	both	8-14wks	N=7	2018

CSNA03:343	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, CC [cm] dist_f30_cont_cc 90329 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:352	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, DO [cm] dist_f30_cont_do 90330 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:361	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders [cm] dist_f30_cocaine_in 90331 day: 1 2 3 5 7 9 11 12 19	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:370	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:379	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO [cm] dist_f30_cocaine_do 90333 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:388	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, founders [cm] dist_l60_cont_in 90382 day: 1 2 3 5 7 9 11 12 19	inbred w/CC8	9	both	8-14wks	N=7	2018

CSNA03:397	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:406	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, DO [cm] dist_l60_cont_do 90384 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:415	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders [cm] dist_l60_cocaine_in 90385 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:424	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC [cm] dist_l60_cocaine_cc 90386 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:433	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO [cm] dist_l60_cocaine_do 90387 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	DO population w/par	9	both	8-21wks	N=27	2018

Eumorphia3:1	Eumorphia3	glucose tolerance	(none)	glucose levels during glucose tolerance test, age 12wks (20% glucose oral, 16h fast) [mg/dL] GLU_12wk 26411 minutes: 0 30 60 90 120 180	inbred	3	both	12wks	N=10	2008

Eumorphia3:7	Eumorphia3	glucose tolerance	(none)	glucose levels during glucose tolerance test, age 24wks (20% glucose oral, 16h fast) [mg/dL] GLU_24wk 26421 minutes: 0 30 60 90 120 180	inbred	4	both	24wks	N=8	2008

Eumorphia3:13	Eumorphia3	glucose tolerance	(none)	glucose levels during glucose tolerance test, age 52wks (20% glucose oral, 16h fast) [mg/dL] GLU_52wk 26431 minutes: 0 30 60 90 120 180	inbred	4	both	52wks	N=8	2008

Eumorphia5:1	Eumorphia5	body temperature	(none)	body temperature (rectal) in cold (4°C) room [°C] temp 26601 hours exposed to cold: 0 1 2 3 4 5 6	inbred	4	both	12wks	N=10	2008

Evsikova1:1	Evsikova1	body weight	(none)	body weight [g] bw 24701 test start test end change	inbred	14	both	26wks	N=7	2009

Evsikova1:66	Evsikova1	intake monitoring	(none)	food intake adjusted for body weight [g/kg] food_adj 24766 test start test end	inbred	14	both	26wks	N=6	2009

GMC01:11	GMC01	open field test	(none)	distance traveled, successive 5 min intervals [cm] distance 55011 1st 5min 2nd 5min 3rd 5min 4th 5min	inbred w/CC8	8	both	8-9wks	N=17	2018

GMC01:21	GMC01	open field test	(none)	number of rears, successive 5 min intervals [n] rears 55021 1st 5min 2nd 5min 3rd 5min 4th 5min	inbred w/CC8	8	both	8-9wks	N=17	2018

GMC01:51	GMC01	open field test	(none)	center distance, successive 5 min intervals [%] center_distance_series 55051 1st 5min 2nd 5min 3rd 5min 4th 5min	inbred w/CC8	8	both	8-9wks	N=17	2018

GMC01:61	GMC01	open field test	(none)	center time, successive 5 min intervals [%] center_time 55061 1st 5min 2nd 5min 3rd 5min 4th 5min	inbred w/CC8	8	both	8-9wks	N=17	2018

GMC06:1	GMC06	body weight	(none)	body weight [g] bw 55501 before fast after 16h fast	inbred w/CC8	8	both	10-11wks	N=14	2018

GMC07:11	GMC07	nociception assay	(none)	latency of nociceptive response to hot plate [s] latency 55611 reaction1 reaction2	inbred w/CC8	8	both	11-12wks	N=17	2018

GMC10:1	GMC10	body weight	(none)	body weight [g] bw 55901 age: 12-13wks 18-19wks	inbred w/CC8	8	both		N=17	2018

GMC10:11	GMC10	NMR	(none)	fat tissue mass, whole body with head (NMR) [g] fat 55911 age: 12-13wks 18-19wks	inbred w/CC8	8	both		N=16	2018

GMC10:21	GMC10	NMR	(none)	lean tissue mass, whole body with head (NMR) [g] lean 55921 age: 12-13wks 18-19wks	inbred w/CC8	8	both		N=16	2018

GMC11:1	GMC11	body weight	(none)	body weight [g] bw 56001 before fast after 16h fast	inbred w/CC8	8	both	13-14wks	N=15	2018

GMC11:3	GMC11	glucose tolerance	(none)	intraperitoneal glucose tolerance test (20% glucose i.p., 16h fast) [mmol/L] GLU 56011 glucose level at minute: 0 15 30 60 120	inbred	6	both	13-14wks	N=15	2018

GMC22:1	GMC22	body weight	(none)	body weight [g] bw 61901 8-9wks 9-10wks 11-12wks 12-13wks 13-14wks 14-15wks 16-17wks 17-18wks 20-21wks	inbred w/CC8	8	both		N=14	2018

Jax1:4	Jax1	body weight	(none)	body weight [g] bw 3604 age (wks): 3 4 5 6 7 8 9 10	inbred	24	both	3wks	N=40	2000

JaxKOMP-EAP:8	JaxKOMP-EAP	open field test	(none)	distance traveled, 20 min test [cm] distance distance_traveled_5min_bins 100239 IMPC_OFD_005_001 1st 5min 2nd 5min 3rd 5min 4th 5min	KOMP	1866	both	8wks	N=9	2021

JaxKOMP-EAP:16	JaxKOMP-EAP	open field test	(none)	number of rears in 5 min bins, 20 min test [n] rears number_of_rears_5min_bins 100249 IMPC_OFD_006_001 1st 5min 2nd 5min 3rd 5min 4th 5min	KOMP	1865	both	8wks	N=9	2021

JaxKOMP-EAP:246	JaxKOMP-EAP	glucose tolerance	(none)	plasma glucose time series plasma_glucose_gtt 100577 0min 15min 30min 60min 120min	KOMP	1825	both	12wks	N=8	2021

JaxKOMP-LAP:8	JaxKOMP-LAP	open field test	(none)	distance traveled, 20 min test [cm] distance distance_traveled_5min_bins 101239 IMPC_OFD_005_001 1st 5min 2nd 5min 3rd 5min 4th 5min	KOMP	118	both	66-72wks	N=8	2021

JaxKOMP-LAP:16	JaxKOMP-LAP	open field test	(none)	number of rears in 5 min bins, 20 min test [n] rears number_of_rears_5min_bins 101249 IMPC_OFD_006_001 1st 5min 2nd 5min 3rd 5min 4th 5min	KOMP	118	both	66-72wks	N=8	2021

JaxKOMP-LAP:229	JaxKOMP-LAP	glucose tolerance	(none)	plasma glucose time series plasma_glucose_gtt 101577 0min 15min 30min 60min 120min	KOMP	121	both	70-76wks	N=7	2021

Jaxpheno5:1	Jaxpheno5	body weight	(none)	body weight [g] bw 23001 age (wks): 3 4 5 6 7 8 9 10 11 12 13 14 15 16	inbred	10	both		N=90	2014

McMullan2:1	McMullan2	running wheel monitoring	(none)	total distance [m] distance 60501 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...	CC	43	f	20-88wks	N=4	2017

McMullan2:31	McMullan2	running wheel monitoring	(none)	total duration [min] duration 60531 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...	CC	43	f	20-88wks	N=4	2017

McMullan2:61	McMullan2	running wheel monitoring	(none)	mean speed [m/min] speed 60561 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...	CC	43	f	20-88wks	N=4	2017

McMullan3:11	McMullan3	body weight	(none)	body weight [g] body_wt 60611 start 2 wks 4 wks	CC	43	f	20-88wks	N=4	2017

McMullan3:21	McMullan3	MRI	(none)	percentage of body mass that is fat [%] fat 60621 start 2 wks 4 wks	CC	43	f	20-88wks	N=4	2017

McMullan3:31	McMullan3	MRI	(none)	percentage of body mass that is lean [%] lean 60631 start 2 wks 4 wks	CC	43	f	20-88wks	N=4	2017

McMullan3:41	McMullan3	body weight	(none)	body weight response [%] body_wt_start 60641 start to 2 wks 2 wks to 4 wks start to 4 wks	CC	43	f	20-88wks	N=4	2017

McMullan3:51	McMullan3	MRI	(none)	fat mass response [%] fat_start 60651 start to 2 wks 2 wks to 4 wks start to 4 wks	CC	43	f	20-88wks	N=4	2017

McMullan3:61	McMullan3	MRI	(none)	lean mass response [%] lean_start 60661 start to 2 wks 2 wks to 4 wks start to 4 wks	CC	43	f	20-88wks	N=4	2017

McMullan3:71	McMullan3	intake monitoring	(none)	food intake [g] food_start 60671 start to 2 wks 2 wks to 4 wks	CC	43	f	20-88wks	N=4	2017

Metten1:1	Metten1	open field test	ethanol	line crossings, 2.75 g/kg i.p. [n] line_doseA 16501 pre-injection 10min after injection 30min after	inbred	9	both	8-11wks	N=4	2004

Metten1:2	Metten1	open field test	ethanol	line crossings, 3.0 g/kg i.p. [n] line_doseB 16502 pre-injection 10min after injection 30min after	inbred	9	both	8-11wks	N=4	2004

Metten1:9	Metten1	behavior observation	ethanol	hindlimb splay, 2.75 g/kg i.p. [score] splay_doseA 16509 10min after injection 30min after	inbred	9	both	8-11wks	N=4	2004

Metten1:11	Metten1	behavior observation	ethanol	hindlimb splay, 3.0 g/kg i.p. [score] splay_doseB 16511 10min after injection 30min after	inbred	9	both	8-11wks	N=4	2004

Metten1:13	Metten1	behavior observation	ethanol	erratic gait, 2.75 g/kg i.p. [score] wobble_doseA 16513 10min after injection 30min after	inbred	9	both	8-11wks	N=4	2004

Metten1:15	Metten1	behavior observation	ethanol	erratic gait, 3.0 g/kg i.p. [score] wobble_doseB 16515 10min after injection 30min after	inbred	9	both	8-11wks	N=4	2004

Nadeau4:28	Nadeau4	body weight	high-fat high-sucrose diet	body weight [g] bw 114391 at age: 4-5 wks 6-7 wks 8-9 wks 10-11 wks 12-13 wks 14-15 wks 17-18 wks 18-19 wks	B6.A consomic w/par	3	m	4-19wks	N=37	2016

Neuner1:1	Neuner1	body weight	(none)	body weight [g] bw 65901 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo	F1 AD-BXD	55	both	8-65wks	N=2	2019

Neuner1:9	Neuner1	biomarker quantification	(none)	temporal cortex amyloid level (ng/mg total protein) [ng/mg] amyloid 65909 6 mo 14 mo	F1 AD-BXD	23	both	23-57wks	N=2	2019

Neuner1:11	Neuner1	metabolic panel	(none)	blood glucose level [mg/dL] glucose 65911 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:13	Neuner1	Y-maze	(none)	percentage spontaneous alternation in Y-maze [%] Ymaze_spon_alt 65913 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo	F1 AD-BXD	55	both	7-65wks	N=2	2019

Neuner1:22	Neuner1	Y-maze	(none)	distance traveled in Y-maze [m] Ymaze_dist 65922 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo	F1 AD-BXD	55	both	8-65wks	N=2	2019

Neuner1:30	Neuner1	Y-maze	(none)	number of arm entries in Y-maze [n] Ymaze_ent 65930 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo	F1 AD-BXD	55	both	8-65wks	N=2	2019

Neuner1:38	Neuner1	Y-maze	(none)	percentage of alternating arm returns in Y-maze [%] Ymaze_returns 65938 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo	F1 AD-BXD	55	both	8-65wks	N=2	2019

Neuner1:46	Neuner1	balance beam	(none)	mean time to cross narrow beam, 3 min test, across 3 trials [s] beam_cross 65946 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:48	Neuner1	inclined screen test	(none)	mean time to right body when placed face down on 45 degree inclined screen (negative geotaxis), 3 min test, across 3 trials [s] neg_geotaxis 65948 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:50	Neuner1	grip strength	(none)	mean grip strength across 3 trials [g] grip_strength 65950 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:52	Neuner1	behavior observation	(none)	sensorimotor composite score across narrow beam, inclined screen, grip strength tasks, derived by Z-scores [score] sensorimotor 65952 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:54	Neuner1	elevated plus maze	(none)	distance traveled in elevated plus maze, 6 min test [m] epm_dist 65954 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:56	Neuner1	elevated plus maze	(none)	number of arm entries in elevated plus maze, 6 min test [n] epm_arm_ent 65956 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:58	Neuner1	elevated plus maze	(none)	percentage of entries into open arms in elevated plus maze, 6 min test [%] epm_open_ent 65958 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:60	Neuner1	elevated plus maze	(none)	percentage of time spent in open arms of elevated plus maze, 6 min test [%] epm_open_time 65960 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Neuner1:62	Neuner1	fear conditioning test	(none)	percentage of time spent freezing during 40 s interval post shock at 6 mo of age, day 1 contextual fear conditioning [%] cfc_6mo 65962 baseline 1st shock 2nd shock 3rd shock 4th shock	F1 AD-BXD	50	both	23-25wks	N=3	2019

Neuner1:67	Neuner1	fear conditioning test	(none)	percentage of time spent freezing during 40 s interval post shock at 14 mo of age, day 1 contextual fear conditioning [%] cfc_14mo 65967 baseline 1st shock 2nd shock 3rd shock 4th shock	F1 AD-BXD	51	both	55-57wks	N=4	2019

Neuner1:72	Neuner1	fear conditioning test	(none)	change in percentage of time spent freezing from 1st post-shock to 4th post-shock (slope), day 1 contextual fear acquisition cfa_change 65972 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=3	2019

Neuner1:74	Neuner1	fear conditioning test	(none)	percentage of time spent freezing at 6 mo of age, day 2 contextual fear memory, 10 min test [%] cfm_6mo 65974 1st 2 min 2nd 2 min 3rd 2 min 4th 2 min 5th 2 min total	F1 AD-BXD	50	both	23-25wks	N=3	2019

Neuner1:80	Neuner1	fear conditioning test	(none)	percentage of time spent freezing at 14 mo of age, day 2 contextual fear memory, 10 min test [%] cfm_14mo 65980 1st 2 min 2nd 2 min 3rd 2 min 4th 2 min 5th 2 min total	F1 AD-BXD	51	both	55-57wks	N=4	2019

Odet2:8	Odet2	microscopy	(none)	percentage of sperm that are motile [%] sperm_motile 53808 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:15	Odet2	microscopy	(none)	percentage of motile sperm that are 'progressive' [%] sperm_prog 53815 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:21	Odet2	microscopy	(none)	percentage of motile sperm that are 'intermediate' [%] sperm_int 53821 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:28	Odet2	microscopy	(none)	percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 53828 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:35	Odet2	microscopy	(none)	percentage of motile sperm that are 'vigorous' [%] sperm_vigor 53835 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:41	Odet2	microscopy	(none)	percentage of motile sperm that are 'slow' [%] sperm_slow 53841 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:48	Odet2	microscopy	(none)	percentage of motile sperm that are 'weak' [%] sperm_weak 53848 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:55	Odet2	microscopy	(none)	sperm mean path velocity [µm/s] sperm_VAP 53855 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:61	Odet2	microscopy	(none)	sperm mean straight line velocity [µm/s] sperm_VSL 53861 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:68	Odet2	microscopy	(none)	sperm mean curvilinear velocity [µm/s] sperm_VCL 53868 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:75	Odet2	microscopy	(none)	sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 53875 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:81	Odet2	microscopy	(none)	sperm mean cross beat frequency [Hz] sperm_BCF 53881 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:88	Odet2	microscopy	(none)	sperm mean straightness [ratio] sperm_STR 53888 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:94	Odet2	microscopy	(none)	sperm mean linearity [ratio] sperm_LIN 53894 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Powell1:1	Powell1	in vitro assay	Neisseria musculi	oral cavity bacterial colony count (CFU/swab) post inoculation (x 10³) [n] bacterial_load 62801 wk 1 wk 2 wk 3 wk 4 wk 5 wk 6 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12	inbred	8	both	8-16wks	N=12	2018

Schonfeld1:2	Schonfeld1	glucose tolerance	(none)	glucose levels during glucose tolerance test(10% glucose i.p., 5h fast) [mg/dL] GTT 32303 0 min 30 min 60 min 120 min	inbred	10	both	9-13wks	N=5	2005

Schonfeld1:6	Schonfeld1	glucose tolerance	(none)	glucose levels, area under curve, glucose tolerance test (10% glucose i.p., 5h fast) [AUC] AUC_GTT 32308 0 to 60 min 0 to 120 min	inbred	10	both	9-13wks	N=5	2005

Schonfeld1:9	Schonfeld1	insulin tolerance	(none)	glucose levels as percent of baseline, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast) [%] pct_ITT 32313 0 min 30 min 60 min 120 min	inbred	10	both	9-13wks	N=5	2005

Schonfeld1:13	Schonfeld1	insulin tolerance	(none)	glucose levels, area under curve, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast) [AUC] AUC_ITT 32318 0 to 60 min 0 to 120 min	inbred	10	both	9-13wks	N=5	2005

Schughart1:1	Schughart1	body weight	influenza A (H1N1) virus	body weight as percent of baseline [%] pctBW 39301 day 1 day 3 day 7 day 12	inbred	9	both	10-12wks	N=10	2009

Schughart2:2	Schughart2	body weight	influenza A (H1N1) virus	body weight as percent of baseline [%] pctbw 49602 day 1 day 3 day 7	BXD w/par	56	f	9-18wks	N=6	2012

Schughart3:11	Schughart3	body weight	influenza A (H3N2) virus	body weight as percent of baseline, 10 FFU group [%] pctbwA 57111 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14	inbred w/CC8	8	both	7-13wks	N=9	2013

Schughart3:31	Schughart3	body weight	influenza A (H3N2) virus	body weight as percent of baseline, 2000 FFU group [%] pctbwB 57131 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14	inbred w/CC8	8	both	7-13wks	N=9	2013

Schughart3:51	Schughart3	body weight	influenza A (H3N2) virus	body weight as percent of baseline, 200,000 FFU group [%] pctbwC 57151 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14	inbred	2	both	7-13wks	N=12	2013

Schughart4:11	Schughart4	body weight	(none)	body weight as percent of baseline, control (saline) group [%] pctbw_ctrl 58711 days post-treatment (saline): 1 2 3	inbred w/CC8	8	f	8-12wks	N=6	2016

Schughart4:21	Schughart4	body weight	influenza A (H3N2) virus	body weight as percent of baseline, infected group [%] pctbw_trt 58721 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 18 30	inbred w/CC8	8	f	8-12wks	N=11	2016

Schughart4:43	Schughart4	complete blood count	influenza A (H3N2) virus	white blood cell count (WBC; per volume x 10³), treated group [n/µL] WBC_trt 58743 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Schughart4:53	Schughart4	complete blood count	influenza A (H3N2) virus	lymphocyte differential (LYM; percentage of total WBC), treated group [%] pctLYM_trt 58753 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Schughart4:63	Schughart4	complete blood count	influenza A (H3N2) virus	monocyte differential (MONO; percentage of total WBC), treated group [%] pctMONO_trt 58763 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Schughart4:73	Schughart4	complete blood count	influenza A (H3N2) virus	granulocyte differential (GRA; percentage of total WBC), treated group [%] pctGRA_trt 58773 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Schughart4:83	Schughart4	in vitro assay	influenza A (H3N2) virus	viral load in lungs (titer, FFU per lung) log10 (x+1) [log(n)] titer_trt 58783 days post-infection: 3 5 8	inbred w/CC8	8	f	8-12wks	N=5	2016

Schughart5:11	Schughart5	body weight	(none)	body weight as percent of baseline [%] pctbw 58811 days post-treatment (saline): 1 2 3	inbred w/CC8	8	f	8-12wks	N=4	2016

Schughart5:21	Schughart5	body weight	influenza A (H3N2) virus	body weight as percent of baseline, 10 FFU group [%] pctbw_trt 58821 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 18 30	inbred w/CC8	8	f	8-12wks	N=9	2016

Seburn1:5	Seburn1	body weight	(none)	body weight [g] bw 9205 start end percent change	inbred	16	both	7-9wks	N=8	2001

Shorter4:14	Shorter4	microscopy	(none)	percentage of sperm that are motile [%] motile 110106 10 min 90 min	CC	12	m	15-33wks	N=3	2019

Shorter4:16	Shorter4	microscopy	(none)	percentage of motile sperm that are 'vigorous' [%] vigorous 110108 10 min 90 min	CC	12	m	15-33wks	N=3	2019

Shorter4:18	Shorter4	microscopy	(none)	percentage of motile sperm that are 'hyperactivated' [%] hyper 110110 10 min 90 min	CC	12	m	15-33wks	N=3	2019

Shorter4:20	Shorter4	microscopy	(none)	sperm mean curvilinear velocity [µm/s] VCL 110112 10 min 90 min	CC	12	m	15-33wks	N=3	2019

Shorter5:14	Shorter5	microscopy	(none)	percentage of sperm that are motile [%] motile 110147 10 min 90 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter5:16	Shorter5	microscopy	(none)	percentage of motile sperm that are 'vigorous' [%] vigorous 110149 10 min 90 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter5:18	Shorter5	microscopy	(none)	percentage of motile sperm that are 'hyperactivated' [%] hyper 110151 10 min 90 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter5:20	Shorter5	microscopy	(none)	sperm mean curvilinear velocity [µm/s] VCL 110153 10 min 90 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter6:1	Shorter6	microscopy	(none)	percentage of sperm that are motile [%] sperm_motile 65601 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:6	Shorter6	microscopy	(none)	percentage of motile sperm that are 'vigorous' [%] sperm_vigor 65606 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:11	Shorter6	microscopy	(none)	percentage of motile sperm that are 'progressive' [%] sperm_prog 65611 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:16	Shorter6	microscopy	(none)	percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 65616 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:21	Shorter6	microscopy	(none)	percentage of motile sperm that are 'intermediate' [%] sperm_int 65621 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:26	Shorter6	microscopy	(none)	percentage of motile sperm that are 'slow' [%] sperm_slow 65626 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:31	Shorter6	microscopy	(none)	percentage of motile sperm that are 'weak' [%] sperm_weak 65631 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:36	Shorter6	microscopy	(none)	sperm mean path velocity [µm/s] sperm_VAP 65636 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:41	Shorter6	microscopy	(none)	sperm mean straight line velocity [µm/s] sperm_VSL 65641 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:46	Shorter6	microscopy	(none)	sperm mean curvilinear velocity [µm/s] sperm_VCL 65646 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:51	Shorter6	microscopy	(none)	sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 65651 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:56	Shorter6	microscopy	(none)	sperm mean cross beat frequency [Hz] sperm_BCF 65656 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:61	Shorter6	microscopy	(none)	sperm mean straightness [ratio] sperm_STR 65661 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter6:66	Shorter6	microscopy	(none)	sperm mean linearity [ratio] sperm_LIN 65666 10 min 30 min 60 min 90 min 120 min	CC	12	m	15-33wks	N=3	2019

Shorter7:1	Shorter7	microscopy	(none)	percentage of sperm that are motile [%] sperm_motile 65701 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:6	Shorter7	microscopy	(none)	percentage of motile sperm that are 'vigorous' [%] sperm_vigor 65706 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:11	Shorter7	microscopy	(none)	percentage of motile sperm that are 'progressive' [%] sperm_prog 65711 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:16	Shorter7	microscopy	(none)	percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 65716 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:21	Shorter7	microscopy	(none)	percentage of motile sperm that are 'intermediate' [%] sperm_int 65721 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:26	Shorter7	microscopy	(none)	percentage of motile sperm that are 'slow' [%] sperm_slow 65726 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:31	Shorter7	microscopy	(none)	percentage of motile sperm that are 'weak' [%] sperm_weak 65731 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:36	Shorter7	microscopy	(none)	sperm mean path velocity [µm/s] sperm_VAP 65736 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:41	Shorter7	microscopy	(none)	sperm mean straight line velocity [µm/s] sperm_VSL 65741 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:46	Shorter7	microscopy	(none)	sperm mean curvilinear velocity [µm/s] sperm_VCL 65746 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:51	Shorter7	microscopy	(none)	sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 65751 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:56	Shorter7	microscopy	(none)	sperm mean cross beat frequency [Hz] sperm_BCF 65756 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:61	Shorter7	microscopy	(none)	sperm mean straightness [ratio] sperm_STR 65761 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Shorter7:66	Shorter7	microscopy	(none)	sperm mean linearity [ratio] sperm_LIN 65766 10 min 30 min 60 min 90 min 120 min	CC RIX	28	m	7-44wks	N=4	2019

Threadgill2:9	Threadgill2	drug and metabolite quantification	acetaminophen	serum acetaminophen (APAP), 50 mg/mL dose acetaminophen [µg/mL] APAP50 39609 baseline 0.5h 1h 2h 3h 6h	inbred	5	m	6-8wks	N=5	2005

Threadgill2:16	Threadgill2	drug and metabolite quantification	acetaminophen	serum acetaminophen sulfate (APAP-sulfate), 50 mg/mL dose acetaminophen [µg/mL] APAP_Sulf_50 39616 baseline 0.5h 1h 2h 3h 6h	inbred	5	m	6-8wks	N=5	2005

Threadgill2:22	Threadgill2	drug and metabolite quantification	acetaminophen	serum acetaminophen glucuronide (APAP-Glc), 50 mg/mL dose acetaminophen [µg/mL] APAP_Glc_50 39622 baseline 0.5h 1h 2h 3h 6h	inbred	5	m	6-8wks	N=4	2005

Threadgill2:32	Threadgill2	drug and metabolite quantification	acetaminophen	serum acetaminophen (APAP), 300 mg/mL dose acetaminophen [µg/mL] APAP300 39632 baseline 0.5h 1h 2h 3h 6h	inbred	5	m	6-8wks	N=5	2005

Threadgill2:38	Threadgill2	drug and metabolite quantification	acetaminophen	serum acetaminophen sulfate (APAP-sulfate), 300 mg/mL dose acetaminophen [µg/mL] APAP_Sulf_300 39638 baseline 0.5h 1h 2h 3h 6h	inbred	5	m	6-8wks	N=5	2005

Threadgill2:39	Threadgill2	drug and metabolite quantification	acetaminophen	serum acetaminophen glucuronide (APAP-Glc), 300 mg/mL dose acetaminophen [µg/mL] APAP_Glc_300 39639 baseline 0.5h 1h 2h 3h 6h	inbred	5	m	6-8wks	N=5	2005

Wahlsten1:20	Wahlsten1	open field test	(none)	distance traveled in 1 min [cm] dist_OFT 10820 during minute: 1 2 3 4 5	inbred	21	both	9wks	N=9	2003

Wahlsten1:40	Wahlsten1	elevated plus maze	(none)	distance traveled in 1 min [cm] dist_EPM 10840 1 2 3 4 5	inbred	21	both	9wks	N=9	2003

Attie2

body weight

high-fat high-sucrose diet

body weight after diet [g] bw 110632 wk: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (5 more)...

DO population

both

5-26wks

N=250

2018

Attie2

body weight

high-fat high-sucrose diet

change in body weight after diet (compared to wk 1) [g] bw_chg 110654 wk: 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

DO population

both

6-21wks

N=250

2018

Attie2

intake monitoring

high-fat high-sucrose diet

food consumption after diet [g] food 110671 wk: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (4 more)...

DO population

both

5-25wks

N=250

2018

Attie2

metabolic panel

high-fat high-sucrose diet

plasma glucose after diet (4h fast) [mg/dL] GLU 110693 wk: 6 10 14 22

DO population

both

10-26wks

N=250

2018

Attie2

hormone quantification

high-fat high-sucrose diet

plasma insulin after diet (4h fast) [ng/mL] INS 110697 wk: 6 10 14 22

DO population

both

10-26wks

N=250

2018

Attie2

lipid profile

high-fat high-sucrose diet

plasma triglyceride after diet (4h fast) [mg/dL] TG 110701 wk: 6 10 14 22

DO population

both

10-26wks

N=250

2018

Bennett1

body weight

(none)

body weight [g] bw 36701 age (days): 30 60 90 120 150 180

ILSXISS

97

f

4wks

N=5

2005

Bennett3

alcohol quantification

ethanol

blood ethanol concentration (BEC) [mg/mL] BEC 37501 first loss of balance (ataxia) first regain of balance second regain of balance

ILSXISS w/par

74

both

8-14wks

N=5

2007

Bolivar1

open field test

(none)

horizontal activity (beam breaks), 5 min test in dark [n] horiz_act 63401 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

number of horizontal movement episodes, 5 min test in dark [n] horiz_bouts 63404 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent moving, 5 min test in dark [%] move_time_pct 63407 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent resting, 5 min test in dark [%] rest_time_pct 63410 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

vertical activity (beam breaks), 5 min test in dark [n] vert_act 63413 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

number of vertical movement episodes, 5 min test in dark [n] vert_bouts 63416 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent vertical, 5 min test in dark [%] vert_time_pct 63419 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

stereotypic activity (beam breaks), 5 min test in dark [n] stereo_act 63422 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

number of stereotypic movement episodes, 5 min test in dark [n] stereo_bouts 63425 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent moving stereotypically, 5 min test in dark [%] stereo_time_pct 63428 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

number of clockwise revolution episodes, 5 min test in dark [n] c_revs 63431 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

number of counter-clockwise revolution episodes, 5 min test in dark [n] cc_revs 63434 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

distance traveled, 5 min test in dark [cm] tot_dist 63437 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

distance traveled in periphery, 5 min test in dark [cm] margin_dist 63440 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent in periphery, 5 min test in dark [%] margin_time_pct 63443 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

distance traveled in center, 5 min test in dark [cm] center_dist 63446 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent in center, 5 min test in dark [%] center_time_pct 63449 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent in left-front of arena, 5 min test in dark [%] LF_time_pct 63452 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent in right-front of arena, 5 min test in dark [%] RF_time_pct 63455 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent in left-rear of arena, 5 min test in dark [%] LR_time_pct 63458 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar1

open field test

(none)

percentage of time spent in right-rear of arena, 5 min test in dark [%] RR_time_pct 63461 day 1 day 2 day 3

inbred

10

both

8-14wks

N=12

2000

Bolivar2

fear conditioning test

(none)

activity (beam breaks) during 2.5 min period of training on day 1 [n] act_shock 63901 before shock after 1st shock after 2nd shock after 3rd shock

inbred

8

both

9-20wks

N=18

2001

Bolivar2

fear conditioning test

(none)

activity (beam breaks) during 1 min period of contextual conditioning on day 2 [n] act_context 63906 1st min 2nd min 3rd min 4th min 5th min mean

inbred

8

both

9-20wks

N=18

2001

Bolivar2

fear conditioning test

(none)

activity (beam breaks) during 1 min period of altered context on day 2 [n] act_altered 63913 1st min 2nd min 3rd min mean

inbred

8

both

9-20wks

N=18

2001

Bolivar2

fear conditioning test

(none)

activity (beam breaks) during 1 min period of cued conditioning on day 2 [n] act_cued 63917 1st min 2nd min 3rd min mean

inbred

8

both

9-20wks

N=18

2001

Bolivar4

open field test

(none)

distance traveled on day 1, 15 min test [cm] dist_5min_d1 64701 first 5 min second 5 min third 5 min

inbred

14

m

8-12wks

N=18

2009

Bolivar4

open field test

(none)

distance traveled, 15 min test [cm] dist_15min 64705 day 1 day 2 day 3

inbred

14

m

8-12wks

N=18

2009

Brinkmeyer1

body weight

Theiler's murine encephalomyelitis virus

body weight, post infection [g] bw 64401 day 0 day 2 day 4 day 6 day 8 day 10 day 14 day 17 day 22 day 27 (6 more)...

CC

5

both

4wks

N=5

2017

Brinkmeyer1

health assessment

Theiler's murine encephalomyelitis virus

clinical score (0=normal, 6=moribund), post infection [score] clin_score 64417 day 0 day 2 day 4 day 6 day 8 day 12 day 18 day 24 day 29 day 34 (6 more)...

CC

5

both

4wks

N=5

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

length of forelimb steps as measured by foot print analysis, post infection [cm] length_fore 64587 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

width of forelimb steps as measured by foot print analysis, post infection [cm] width_fore 64594 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

length of hindlimb steps as measured by foot print analysis, post infection [cm] length_hind 64601 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

width of hindlimb steps as measured by foot print analysis, post infection [cm] width_hind 64608 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Cheverud1

body weight

(none)

body weight on control diet [g] bw_ctrl 17801 age (wks): 4 5 6 7 9 11 15 19 23

LGXSM w/par

17

both

12-16wks

N=8

2004

Cheverud1

body weight

high-fat diet

body weight on high-fat diet [g] bw_hifat 17851 age (wks): 4 5 6 7 9 11 15 19 23

LGXSM w/par

18

both

12-16wks

N=8

2004

Crabbe4

alcohol quantification

ethanol

blood ethanol concentration [mg/mL] BEC 19112 time after ethanol: 30min 60min 105min 150min

inbred

21

both

7-12wks

N=6

2003

Crowley1

body weight

haloperidol

body weight [g] bw 39401 starting ending

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

drug and metabolite quantification

haloperidol

plasma haloperidol concentration [nM] haloperidol 39403 day: 30 60 90 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

inclined screen test

haloperidol

latency to move four paws, extrapyramidal side effects [s] latency 39407 day: 0 3 7 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

open field test

haloperidol

distance traveled, 60 min test [cm] horizontal_act 39412 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

open field test

haloperidol

vertical activity, beam breaks, 60 min test [n] vertical_act 39417 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

open field test

haloperidol

repetitive behavior, breaking of same beam, 60 min test [n] stereotypy 39421 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

open field test

haloperidol

center occupancy, percentage of total time [%] pct_center 39425 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

behavior observation

haloperidol

tongue protrusions, 15 min test [n] tongue 39429 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

behavior observation

haloperidol

overt chewing movements, 15 min test [n] overtchew 39433 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

behavior observation

haloperidol

subtle chewing movements, 15 min test [n] subtlechew 39437 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crowley1

behavior observation

haloperidol

jaw tremor duration, 15 min test [s] jawtremor 39441 day: 0 30 60 120

inbred w/CC8

27

m

9-28wks

N=6

2012

Crusio1

radial maze

(none)

time to complete task [s] task_time 62016 day 1 day 2 day 3 day 4 day 5

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

radial maze

(none)

number of different arms visited during first 8 arm choices of a trial [n] num_arms 62021 day 1 day 2 day 3 day 4 day 5

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

radial maze

(none)

number of different arms visited during first 8 arm choices of a trial minus 5.3 (number expected by chance) [n] num_arms_adj 62026 day 3 day 4 day 5 mean

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

radial maze

(none)

number of errors made before all 8 rewards collected [n] errors 62030 day 1 day 2 day 3 day 4 day 5 sum of days 3 4 5

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

radial maze

(none)

mean duration per arm visit (including errors) [s] visit_time 62036 day 3 day 4 day 5 mean

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

behavior observation

(none)

attack latency [s] latency 62040 day 1 day 2

BXD w/par

55

m

12-16wks

N=8

2018

Crusio1

behavior observation

(none)

whether an animal attacks (0=no, 1=yes) [score] attack 62042 day 1 day 2

BXD w/par

55

m

12-16wks

N=8

2018

CSNA02

open field test

(none)

distance traveled, 40 min test [cm] locomotor 62201 day 1 day 2 day 2 minus day 1

inbred

10

both

10wks

N=8

2018

CSNA02

body weight

(none)

body weight for ethanol study [g] bw 62220 day 1 day 2 day 3

inbred

18

both

16-39wks

N=6

2018

CSNA02

bottle choice test

ethanol

ethanol consumption adjusted per kg body weight 'drinking in the dark' [g/kg] EtOH_adj 62223 day 1 day 2 day 3

inbred

18

both

16-39wks

N=6

2018

CSNA02

bottle choice test

ethanol

licks on ethanol bottle as a percentage of total licks 'drinking in the dark' [%] EtOH_licks 62226 day 1 day 2 day 3

inbred

18

both

16-39wks

N=5

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), founders [cm] amb_dist_OFT_in 90019 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), DO [cm] amb_dist_OFT_do 90021 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, founders [cm] dist_f30_cont_in 90328 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

9

both

8-14wks

N=7

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, CC [cm] dist_f30_cont_cc 90329 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, DO [cm] dist_f30_cont_do 90330 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders [cm] dist_f30_cocaine_in 90331 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO [cm] dist_f30_cocaine_do 90333 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, founders [cm] dist_l60_cont_in 90382 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

9

both

8-14wks

N=7

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, DO [cm] dist_l60_cont_do 90384 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders [cm] dist_l60_cocaine_in 90385 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC [cm] dist_l60_cocaine_cc 90386 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO [cm] dist_l60_cocaine_do 90387 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

DO population w/par

9

both

8-21wks

N=27

2018

Eumorphia3

glucose tolerance

(none)

glucose levels during glucose tolerance test, age 12wks (20% glucose oral, 16h fast) [mg/dL] GLU_12wk 26411 minutes: 0 30 60 90 120 180

inbred

3

both

12wks

N=10

2008

Eumorphia3

glucose tolerance

(none)

glucose levels during glucose tolerance test, age 24wks (20% glucose oral, 16h fast) [mg/dL] GLU_24wk 26421 minutes: 0 30 60 90 120 180

inbred

4

both

24wks

N=8

2008

Eumorphia3

glucose tolerance

(none)

glucose levels during glucose tolerance test, age 52wks (20% glucose oral, 16h fast) [mg/dL] GLU_52wk 26431 minutes: 0 30 60 90 120 180

inbred

4

both

52wks

N=8

2008

Eumorphia5

body temperature

(none)

body temperature (rectal) in cold (4°C) room [°C] temp 26601 hours exposed to cold: 0 1 2 3 4 5 6

inbred

4

both

12wks

N=10

2008

Evsikova1

body weight

(none)

body weight [g] bw 24701 test start test end change

inbred

14

both

26wks

N=7

2009

Evsikova1

intake monitoring

(none)

food intake adjusted for body weight [g/kg] food_adj 24766 test start test end

inbred

14

both

26wks

N=6

2009

GMC01

open field test

(none)

distance traveled, successive 5 min intervals [cm] distance 55011 1st 5min 2nd 5min 3rd 5min 4th 5min

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

number of rears, successive 5 min intervals [n] rears 55021 1st 5min 2nd 5min 3rd 5min 4th 5min

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

center distance, successive 5 min intervals [%] center_distance_series 55051 1st 5min 2nd 5min 3rd 5min 4th 5min

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC01

open field test

(none)

center time, successive 5 min intervals [%] center_time 55061 1st 5min 2nd 5min 3rd 5min 4th 5min

inbred w/CC8

8

both

8-9wks

N=17

2018

GMC06

body weight

(none)

body weight [g] bw 55501 before fast after 16h fast

inbred w/CC8

8

both

10-11wks

N=14

2018

GMC07

nociception assay

(none)

latency of nociceptive response to hot plate [s] latency 55611 reaction1 reaction2

inbred w/CC8

8

both

11-12wks

N=17

2018

GMC10

body weight

(none)

body weight [g] bw 55901 age: 12-13wks 18-19wks

inbred w/CC8

8

both

N=17

2018

GMC10

NMR

(none)

fat tissue mass, whole body with head (NMR) [g] fat 55911 age: 12-13wks 18-19wks

inbred w/CC8

8

both

N=16

2018

GMC10

NMR

(none)

lean tissue mass, whole body with head (NMR) [g] lean 55921 age: 12-13wks 18-19wks

inbred w/CC8

8

both

N=16

2018

GMC11

body weight

(none)

body weight [g] bw 56001 before fast after 16h fast

inbred w/CC8

8

both

13-14wks

N=15

2018

GMC11

glucose tolerance

(none)

intraperitoneal glucose tolerance test (20% glucose i.p., 16h fast) [mmol/L] GLU 56011 glucose level at minute: 0 15 30 60 120

inbred

6

both

13-14wks

N=15

2018

GMC22

body weight

(none)

body weight [g] bw 61901 8-9wks 9-10wks 11-12wks 12-13wks 13-14wks 14-15wks 16-17wks 17-18wks 20-21wks

inbred w/CC8

8

both

N=14

2018

Jax1

body weight

(none)

body weight [g] bw 3604 age (wks): 3 4 5 6 7 8 9 10

inbred

24

both

3wks

N=40

2000

JaxKOMP-EAP

open field test

(none)

distance traveled, 20 min test [cm] distance distance_traveled_5min_bins 100239 IMPC_OFD_005_001 1st 5min 2nd 5min 3rd 5min 4th 5min

KOMP

1866

both

8wks

N=9

2021

JaxKOMP-EAP

open field test

(none)

number of rears in 5 min bins, 20 min test [n] rears number_of_rears_5min_bins 100249 IMPC_OFD_006_001 1st 5min 2nd 5min 3rd 5min 4th 5min

KOMP

1865

both

8wks

N=9

2021

JaxKOMP-EAP

glucose tolerance

(none)

plasma glucose time series plasma_glucose_gtt 100577 0min 15min 30min 60min 120min

KOMP

1825

both

12wks

N=8

2021

JaxKOMP-LAP

open field test

(none)

distance traveled, 20 min test [cm] distance distance_traveled_5min_bins 101239 IMPC_OFD_005_001 1st 5min 2nd 5min 3rd 5min 4th 5min

KOMP

118

both

66-72wks

N=8

2021

JaxKOMP-LAP

open field test

(none)

number of rears in 5 min bins, 20 min test [n] rears number_of_rears_5min_bins 101249 IMPC_OFD_006_001 1st 5min 2nd 5min 3rd 5min 4th 5min

KOMP

118

both

66-72wks

N=8

2021

JaxKOMP-LAP

glucose tolerance

(none)

plasma glucose time series plasma_glucose_gtt 101577 0min 15min 30min 60min 120min

KOMP

121

both

70-76wks

N=7

2021

Jaxpheno5

body weight

(none)

body weight [g] bw 23001 age (wks): 3 4 5 6 7 8 9 10 11 12 13 14 15 16

inbred

10

both

N=90

2014

McMullan2

running wheel monitoring

(none)

total distance [m] distance 60501 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...

CC

43

f

20-88wks

N=4

2017

McMullan2

running wheel monitoring

(none)

total duration [min] duration 60531 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...

CC

43

f

20-88wks

N=4

2017

McMullan2

running wheel monitoring

(none)

mean speed [m/min] speed 60561 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...

CC

43

f

20-88wks

N=4

2017

McMullan3

body weight

(none)

body weight [g] body_wt 60611 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

percentage of body mass that is fat [%] fat 60621 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

percentage of body mass that is lean [%] lean 60631 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

body weight

(none)

body weight response [%] body_wt_start 60641 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

fat mass response [%] fat_start 60651 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

lean mass response [%] lean_start 60661 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

intake monitoring

(none)

food intake [g] food_start 60671 start to 2 wks 2 wks to 4 wks

CC

43

f

20-88wks

N=4

2017

Metten1

open field test

ethanol

line crossings, 2.75 g/kg i.p. [n] line_doseA 16501 pre-injection 10min after injection 30min after

inbred

9

both

8-11wks

N=4

2004

Metten1

open field test

ethanol

line crossings, 3.0 g/kg i.p. [n] line_doseB 16502 pre-injection 10min after injection 30min after

inbred

9

both

8-11wks

N=4

2004

Metten1

behavior observation

ethanol

hindlimb splay, 2.75 g/kg i.p. [score] splay_doseA 16509 10min after injection 30min after

inbred

9

both

8-11wks

N=4

2004

Metten1

behavior observation

ethanol

hindlimb splay, 3.0 g/kg i.p. [score] splay_doseB 16511 10min after injection 30min after

inbred

9

both

8-11wks

N=4

2004

Metten1

behavior observation

ethanol

erratic gait, 2.75 g/kg i.p. [score] wobble_doseA 16513 10min after injection 30min after

inbred

9

both

8-11wks

N=4

2004

Metten1

behavior observation

ethanol

erratic gait, 3.0 g/kg i.p. [score] wobble_doseB 16515 10min after injection 30min after

inbred

9

both

8-11wks

N=4

2004

Nadeau4

body weight

high-fat high-sucrose diet

body weight [g] bw 114391 at age: 4-5 wks 6-7 wks 8-9 wks 10-11 wks 12-13 wks 14-15 wks 17-18 wks 18-19 wks

B6.A consomic w/par

3

m

4-19wks

N=37

2016

Neuner1

body weight

(none)

body weight [g] bw 65901 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo

F1 AD-BXD

55

both

8-65wks

N=2

2019

Neuner1

biomarker quantification

(none)

temporal cortex amyloid level (ng/mg total protein) [ng/mg] amyloid 65909 6 mo 14 mo

F1 AD-BXD

23

both

23-57wks

N=2

2019

Neuner1

metabolic panel

(none)

blood glucose level [mg/dL] glucose 65911 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

Y-maze

(none)

percentage spontaneous alternation in Y-maze [%] Ymaze_spon_alt 65913 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo

F1 AD-BXD

55

both

7-65wks

N=2

2019

Neuner1

Y-maze

(none)

distance traveled in Y-maze [m] Ymaze_dist 65922 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo

F1 AD-BXD

55

both

8-65wks

N=2

2019

Neuner1

Y-maze

(none)

number of arm entries in Y-maze [n] Ymaze_ent 65930 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo

F1 AD-BXD

55

both

8-65wks

N=2

2019

Neuner1

Y-maze

(none)

percentage of alternating arm returns in Y-maze [%] Ymaze_returns 65938 2 mo 4 mo 6 mo 8 mo 10 mo 12 mo 14 mo 16 mo

F1 AD-BXD

55

both

8-65wks

N=2

2019

Neuner1

balance beam

(none)

mean time to cross narrow beam, 3 min test, across 3 trials [s] beam_cross 65946 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

inclined screen test

(none)

mean time to right body when placed face down on 45 degree inclined screen (negative geotaxis), 3 min test, across 3 trials [s] neg_geotaxis 65948 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

grip strength

(none)

mean grip strength across 3 trials [g] grip_strength 65950 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

behavior observation

(none)

sensorimotor composite score across narrow beam, inclined screen, grip strength tasks, derived by Z-scores [score] sensorimotor 65952 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

elevated plus maze

(none)

distance traveled in elevated plus maze, 6 min test [m] epm_dist 65954 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

elevated plus maze

(none)

number of arm entries in elevated plus maze, 6 min test [n] epm_arm_ent 65956 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

elevated plus maze

(none)

percentage of entries into open arms in elevated plus maze, 6 min test [%] epm_open_ent 65958 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

elevated plus maze

(none)

percentage of time spent in open arms of elevated plus maze, 6 min test [%] epm_open_time 65960 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=6

2019

Neuner1

fear conditioning test

(none)

percentage of time spent freezing during 40 s interval post shock at 6 mo of age, day 1 contextual fear conditioning [%] cfc_6mo 65962 baseline 1st shock 2nd shock 3rd shock 4th shock

F1 AD-BXD

50

both

23-25wks

N=3

2019

Neuner1

fear conditioning test

(none)

percentage of time spent freezing during 40 s interval post shock at 14 mo of age, day 1 contextual fear conditioning [%] cfc_14mo 65967 baseline 1st shock 2nd shock 3rd shock 4th shock

F1 AD-BXD

51

both

55-57wks

N=4

2019

Neuner1

fear conditioning test

(none)

change in percentage of time spent freezing from 1st post-shock to 4th post-shock (slope), day 1 contextual fear acquisition cfa_change 65972 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=3

2019

Neuner1

fear conditioning test

(none)

percentage of time spent freezing at 6 mo of age, day 2 contextual fear memory, 10 min test [%] cfm_6mo 65974 1st 2 min 2nd 2 min 3rd 2 min 4th 2 min 5th 2 min total

F1 AD-BXD

50

both

23-25wks

N=3

2019

Neuner1

fear conditioning test

(none)

percentage of time spent freezing at 14 mo of age, day 2 contextual fear memory, 10 min test [%] cfm_14mo 65980 1st 2 min 2nd 2 min 3rd 2 min 4th 2 min 5th 2 min total

F1 AD-BXD

51

both

55-57wks

N=4

2019

Odet2

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 53808 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'progressive' [%] sperm_prog 53815 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'intermediate' [%] sperm_int 53821 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 53828 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] sperm_vigor 53835 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'slow' [%] sperm_slow 53841 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

percentage of motile sperm that are 'weak' [%] sperm_weak 53848 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean path velocity [µm/s] sperm_VAP 53855 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean straight line velocity [µm/s] sperm_VSL 53861 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean curvilinear velocity [µm/s] sperm_VCL 53868 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 53875 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean cross beat frequency [Hz] sperm_BCF 53881 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean straightness [ratio] sperm_STR 53888 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Odet2

microscopy

(none)

sperm mean linearity [ratio] sperm_LIN 53894 min: 10 30 60 90 120

inbred w/CC8

8

m

10-66wks

N=13

2015

Powell1

in vitro assay

Neisseria musculi

oral cavity bacterial colony count (CFU/swab) post inoculation (x 10³) [n] bacterial_load 62801 wk 1 wk 2 wk 3 wk 4 wk 5 wk 6 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12

inbred

8

both

8-16wks

N=12

2018

Schonfeld1

glucose tolerance

(none)

glucose levels during glucose tolerance test(10% glucose i.p., 5h fast) [mg/dL] GTT 32303 0 min 30 min 60 min 120 min

inbred

10

both

9-13wks

N=5

2005

Schonfeld1

glucose tolerance

(none)

glucose levels, area under curve, glucose tolerance test (10% glucose i.p., 5h fast) [AUC] AUC_GTT 32308 0 to 60 min 0 to 120 min

inbred

10

both

9-13wks

N=5

2005

Schonfeld1

insulin tolerance

(none)

glucose levels as percent of baseline, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast) [%] pct_ITT 32313 0 min 30 min 60 min 120 min

inbred

10

both

9-13wks

N=5

2005

Schonfeld1

insulin tolerance

(none)

glucose levels, area under curve, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast) [AUC] AUC_ITT 32318 0 to 60 min 0 to 120 min

inbred

10

both

9-13wks

N=5

2005

Schughart1

body weight

influenza A (H1N1) virus

body weight as percent of baseline [%] pctBW 39301 day 1 day 3 day 7 day 12

inbred

9

both

10-12wks

N=10

2009

Schughart2

body weight

influenza A (H1N1) virus

body weight as percent of baseline [%] pctbw 49602 day 1 day 3 day 7

BXD w/par

56

f

9-18wks

N=6

2012

Schughart3

body weight

influenza A (H3N2) virus

body weight as percent of baseline, 10 FFU group [%] pctbwA 57111 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

inbred w/CC8

8

both

7-13wks

N=9

2013

Schughart3

body weight

influenza A (H3N2) virus

body weight as percent of baseline, 2000 FFU group [%] pctbwB 57131 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

inbred w/CC8

8

both

7-13wks

N=9

2013

Schughart3

body weight

influenza A (H3N2) virus

body weight as percent of baseline, 200,000 FFU group [%] pctbwC 57151 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

inbred

2

both

7-13wks

N=12

2013

Schughart4

body weight

(none)

body weight as percent of baseline, control (saline) group [%] pctbw_ctrl 58711 days post-treatment (saline): 1 2 3

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

body weight

influenza A (H3N2) virus

body weight as percent of baseline, infected group [%] pctbw_trt 58721 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 18 30

inbred w/CC8

8

f

8-12wks

N=11

2016

Schughart4

complete blood count

influenza A (H3N2) virus

white blood cell count (WBC; per volume x 10³), treated group [n/µL] WBC_trt 58743 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

complete blood count

influenza A (H3N2) virus

lymphocyte differential (LYM; percentage of total WBC), treated group [%] pctLYM_trt 58753 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

complete blood count

influenza A (H3N2) virus

monocyte differential (MONO; percentage of total WBC), treated group [%] pctMONO_trt 58763 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

complete blood count

influenza A (H3N2) virus

granulocyte differential (GRA; percentage of total WBC), treated group [%] pctGRA_trt 58773 days post-infection: 3 5 8 18 30

inbred w/CC8

8

f

8-12wks

N=6

2016

Schughart4

in vitro assay

influenza A (H3N2) virus

viral load in lungs (titer, FFU per lung) log10 (x+1) [log(n)] titer_trt 58783 days post-infection: 3 5 8

inbred w/CC8

8

f

8-12wks

N=5

2016

Schughart5

body weight

(none)

body weight as percent of baseline [%] pctbw 58811 days post-treatment (saline): 1 2 3

inbred w/CC8

8

f

8-12wks

N=4

2016

Schughart5

body weight

influenza A (H3N2) virus

body weight as percent of baseline, 10 FFU group [%] pctbw_trt 58821 days post-infection: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 18 30

inbred w/CC8

8

f

8-12wks

N=9

2016

Seburn1

body weight

(none)

body weight [g] bw 9205 start end percent change

inbred

16

both

7-9wks

N=8

2001

Shorter4

microscopy

(none)

percentage of sperm that are motile [%] motile 110106 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] vigorous 110108 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] hyper 110110 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

sperm mean curvilinear velocity [µm/s] VCL 110112 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter5

microscopy

(none)

percentage of sperm that are motile [%] motile 110147 10 min 90 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter5

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] vigorous 110149 10 min 90 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter5

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] hyper 110151 10 min 90 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter5

microscopy

(none)

sperm mean curvilinear velocity [µm/s] VCL 110153 10 min 90 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter6

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 65601 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] sperm_vigor 65606 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'progressive' [%] sperm_prog 65611 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 65616 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'intermediate' [%] sperm_int 65621 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'slow' [%] sperm_slow 65626 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'weak' [%] sperm_weak 65631 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean path velocity [µm/s] sperm_VAP 65636 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean straight line velocity [µm/s] sperm_VSL 65641 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean curvilinear velocity [µm/s] sperm_VCL 65646 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 65651 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean cross beat frequency [Hz] sperm_BCF 65656 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean straightness [ratio] sperm_STR 65661 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean linearity [ratio] sperm_LIN 65666 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter7

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 65701 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] sperm_vigor 65706 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

percentage of motile sperm that are 'progressive' [%] sperm_prog 65711 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 65716 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

percentage of motile sperm that are 'intermediate' [%] sperm_int 65721 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

percentage of motile sperm that are 'slow' [%] sperm_slow 65726 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

percentage of motile sperm that are 'weak' [%] sperm_weak 65731 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

sperm mean path velocity [µm/s] sperm_VAP 65736 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

sperm mean straight line velocity [µm/s] sperm_VSL 65741 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

sperm mean curvilinear velocity [µm/s] sperm_VCL 65746 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 65751 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

sperm mean cross beat frequency [Hz] sperm_BCF 65756 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

sperm mean straightness [ratio] sperm_STR 65761 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Shorter7

microscopy

(none)

sperm mean linearity [ratio] sperm_LIN 65766 10 min 30 min 60 min 90 min 120 min

CC RIX

28

m

7-44wks

N=4

2019

Threadgill2

drug and metabolite quantification

acetaminophen

serum acetaminophen (APAP), 50 mg/mL dose acetaminophen [µg/mL] APAP50 39609 baseline 0.5h 1h 2h 3h 6h

inbred

5

m

6-8wks

N=5

2005

Threadgill2

drug and metabolite quantification

acetaminophen

serum acetaminophen sulfate (APAP-sulfate), 50 mg/mL dose acetaminophen [µg/mL] APAP_Sulf_50 39616 baseline 0.5h 1h 2h 3h 6h

inbred

5

m

6-8wks

N=5

2005

Threadgill2

drug and metabolite quantification

acetaminophen

serum acetaminophen glucuronide (APAP-Glc), 50 mg/mL dose acetaminophen [µg/mL] APAP_Glc_50 39622 baseline 0.5h 1h 2h 3h 6h

inbred

5

m

6-8wks

N=4

2005

Threadgill2

drug and metabolite quantification

acetaminophen

serum acetaminophen (APAP), 300 mg/mL dose acetaminophen [µg/mL] APAP300 39632 baseline 0.5h 1h 2h 3h 6h

inbred

5

m

6-8wks

N=5

2005

Threadgill2

drug and metabolite quantification

acetaminophen

serum acetaminophen sulfate (APAP-sulfate), 300 mg/mL dose acetaminophen [µg/mL] APAP_Sulf_300 39638 baseline 0.5h 1h 2h 3h 6h

inbred

5

m

6-8wks

N=5

2005

Threadgill2

drug and metabolite quantification

acetaminophen

serum acetaminophen glucuronide (APAP-Glc), 300 mg/mL dose acetaminophen [µg/mL] APAP_Glc_300 39639 baseline 0.5h 1h 2h 3h 6h

inbred

5

m

6-8wks

N=5

2005

Wahlsten1

open field test

(none)

distance traveled in 1 min [cm] dist_OFT 10820 during minute: 1 2 3 4 5

inbred

21

both

9wks

N=9

2003

Wahlsten1

elevated plus maze

(none)

distance traveled in 1 min [cm] dist_EPM 10840 1 2 3 4 5

inbred

21

both

9wks

N=9

2003

Study designs: all MPD measure sets of study design type timecourse

Filter Table Results